carbachol has been researched along with Pneumonia, Bacterial in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Pneumonia, Bacterial: Inflammation of the lung parenchyma that is caused by bacterial infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elekes, K | 1 |
| Helyes, Z | 1 |
| Kereskai, L | 1 |
| Sándor, K | 1 |
| Pintér, E | 1 |
| Pozsgai, G | 1 |
| Tékus, V | 1 |
| Bánvölgyi, A | 1 |
| Németh, J | 1 |
| Szuts, T | 1 |
| Kéri, G | 1 |
| Szolcsányi, J | 1 |
1 other study available for carbachol and Pneumonia, Bacterial
| Article | Year |
|---|---|
Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; B | 2008 |